Real-time enrollment status for this recurrent t-cell non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 9:26 PM UTC
| NCT Number | NCT07225985 |
| Recruiting Status | Recruiting |
| Condition | Recurrent T-Cell Non-Hodgkin Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fred Hutchinson Cancer Center |
| Last Updated on CT.gov | May 11, 2026 (May 11, 2026) |
As of July 16, 2026: Clinical trial NCT07225985 is currently recruiting participants. This phase1 study for recurrent t-cell non-hodgkin lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Fred Hutchinson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07225985 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07225985 was last updated May 11, 2026 (May 11, 2026). HelloStudys verifies this status automatically.